Diabetes, Vol 37, Issue 11 1499-1504, Copyright © 1988 by American Diabetes Association

ARTICLES

Effect of proteinuria on mortality in NIDDM

RG Nelson, DJ Pettitt, MJ Carraher, HR Baird and WC Knowler
Diabetes and Arthritis Epidemiology Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ 85014.

The effect of proteinuria (greater than or equal to approximately 1 g/day) on mortality in non-insulin-dependent diabetes mellitus (NIDDM) was assessed in Pima Indians aged greater than or equal to 45 yr. Among 1426 subjects, 48% with NIDDM at the beginning of followup, there were 489 deaths in 13,345 person-yr of observation. The age- and sex-adjusted mortality rate was 32.7/1000 person-yr (95% Cl = 27.6, 37.8) in diabetic subjects without proteinuria, similar to the rate of 30.1/1000 person-yr (95% Cl = 25.7, 34.4) in nondiabetic subjects without proteinuria. By contrast, in diabetic subjects with proteinuria the mortality rate was 121.4/1000 person-yr (95% Cl = 97.5, 145.3). When controlled for age, sex, and diabetes duration, diabetic subjects with proteinuria had a death rate 3.5 times as high (95% Cl = 2.8, 4.4) as those without proteinuria. Of the excess mortality associated with NIDDM in Pima Indians, 97% was found in subjects with proteinuria. The death rate in diabetic subjects without proteinuria was not appreciably greater than the rate in nondiabetic subjects. Mortality rates from uremia and cardiovascular disease were significantly higher in diabetic Pima Indians with proteinuria than in those without. These relationships are similar to observations reported in people with insulin-dependent diabetes.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Soma, K. Sato, H. Saito, and Y. Tsuchiya Effect of tranilast in early-stage diabetic nephropathy Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2795 - 2799. [Abstract] [Full Text] [PDF]

				R. S. Vasan Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations Circulation, May 16, 2006; 113(19): 2335 - 2362. [Full Text] [PDF]

				J. R. Madison, C. Spies, I. J. Schatz, K. Masaki, R. Chen, K. Yano, and J. D. Curb Proteinuria and Risk for Stroke and Coronary Heart Disease During 27 Years of Follow-up: The Honolulu Heart Program. Arch Intern Med, April 24, 2006; 166(8): 884 - 889. [Abstract] [Full Text] [PDF]

				B. V. Howard, L. G. Best, J. M. Galloway, W. J. Howard, K. Jones, E. T. Lee, R. E. Ratner, H. E. Resnick, and R. B. Devereux Coronary Heart Disease Risk Equivalence in Diabetes Depends on Concomitant Risk Factors Diabetes Care, February 1, 2006; 29(2): 391 - 397. [Abstract] [Full Text] [PDF]

				J. N. Cohn, A. A. Quyyumi, N. K. Hollenberg, and K. A. Jamerson Surrogate Markers for Cardiovascular Disease: Functional Markers Circulation, June 29, 2004; 109(25_suppl_1): IV-31 - IV-46. [Full Text] [PDF]

				M. E. Pavkov, M. L. Sievers, W. C. Knowler, P. H. Bennett, and R. G. Nelson An Explanation for the Increase in Heart Disease Mortality Rates in Diabetic Pima Indians: Effect of renal replacement therapy Diabetes Care, May 1, 2004; 27(5): 1132 - 1136. [Abstract] [Full Text] [PDF]

				B. A. Young, C. Maynard, and E. J. Boyko Racial Differences in Diabetic Nephropathy, Cardiovascular Disease, and Mortality in a National Population of Veterans Diabetes Care, August 1, 2003; 26(8): 2392 - 2399. [Abstract] [Full Text] [PDF]

				J. Krakoff, R. S. Lindsay, H. C. Looker, R. G. Nelson, R. L. Hanson, and W. C. Knowler Incidence of Retinopathy and Nephropathy in Youth-Onset Compared With Adult-Onset Type 2 Diabetes Diabetes Care, January 1, 2003; 26(1): 76 - 81. [Abstract] [Full Text] [PDF]

				A. N. Friedman, L. G. Hunsicker, J. Selhub, A. G. Bostom, and The Collaborative Study Group Proteinuria as a Predictor of Total Plasma Homocysteine Levels in Type 2 Diabetic Nephropathy Diabetes Care, November 1, 2002; 25(11): 2037 - 2041. [Abstract] [Full Text] [PDF]

				S. Fava and A. T. Hattersley The role of genetic susceptibility in diabetic nephropathy: evidence from family studies Nephrol. Dial. Transplant., September 1, 2002; 17(9): 1543 - 1546. [Full Text] [PDF]

				E.B. Jude, S.G. Anderson, J.K. Cruickshank, A. Srivatsa, N. Tentolouris, R. Chandrasekaran, R. Gokal, and A.J.M. Boulton Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes QJM, June 1, 2002; 95(6): 371 - 377. [Abstract] [Full Text] [PDF]

				J. J. Caro, A. J. Ward, and J. A. O'Brien Lifetime Costs of Complications Resulting From Type 2 Diabetes in the U.S. Diabetes Care, March 1, 2002; 25(3): 476 - 481. [Abstract] [Full Text] [PDF]

				S. Fava, J. Azzopardi, S. Ellard, and A. T. Hattersley ACE Gene Polymorphism as a Prognostic Indicator in Patients With Type 2 Diabetes and Established Renal Disease Diabetes Care, December 1, 2001; 24(12): 2115 - 2120. [Abstract] [Full Text] [PDF]

				J. A. D'Elia, L. A. Weinrauch, R. E. Gleason, I. Lipinska, J. Keough, S. Pendse, B. Roshan, A. T. Lee, and G. H. Tofler Fibrinogen and Factor VII Levels Improve With Glycemic Control in Patients With Type 1 Diabetes Mellitus Who Have Microvascular Complications Arch Intern Med, January 8, 2001; 161(1): 98 - 101. [Abstract] [Full Text] [PDF]

				C. T. Valmadrid, R. Klein, S. E. Moss, and B. E. K. Klein The Risk of Cardiovascular Disease Mortality Associated With Microalbuminuria and Gross Proteinuria in Persons With Older-Onset Diabetes Mellitus Arch Intern Med, April 24, 2000; 160(8): 1093 - 1100. [Abstract] [Full Text] [PDF]

				J. SOMA, T. SAITO, Y. TAGUMA, S. CHIBA, H. SATO, K. SUGIMURA, S. OGAWA, and S. ITO High Prevalence and Adverse Effect of Hepatitis C Virus Infection in Type II Diabetic-Related Nephropathy J. Am. Soc. Nephrol., April 1, 2000; 11(4): 690 - 699. [Abstract] [Full Text] [PDF]

				S. M. Grundy, I. J. Benjamin, G. L. Burke, A. Chait, R. H. Eckel, B. V. Howard, W. Mitch, S. C. Smith Jr, and J. R. Sowers Diabetes and Cardiovascular Disease : A Statement for Healthcare Professionals From the American Heart Association Circulation, September 7, 1999; 100(10): 1134 - 1146. [Full Text] [PDF]

				M. L. Sievers, P. H. Bennett, J. Roumain, and R. G. Nelson Effect of Hypertension on Mortality in Pima Indians Circulation, July 6, 1999; 100(1): 33 - 40. [Abstract] [Full Text] [PDF]

				A. Fagot-Campagna, R. L. Hanson, K. M. V. Narayan, M. L. Sievers, D. J. Pettitt, R. G. Nelson, and W. C. Knowler Serum Cholesterol and Mortality Rates in a Native American Population With Low Cholesterol Concentrations : A U-Shaped Association Circulation, September 2, 1997; 96(5): 1408 - 1415. [Abstract] [Full Text]

				H. Miettinen, S. M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Proteinuria Predicts Stroke and Other Atherosclerotic Vascular Disease Events in Nondiabetic and Non–Insulin-Dependent Diabetic Subjects Stroke, November 1, 1996; 27(11): 2033 - 2039. [Abstract] [Full Text]